{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["32(3)"],"submitter":["Zuckerman AD"],"pubmed_abstract":["<h4>Background</h4>Though specialty pharmacies collect and report a myriad of measures to internal and external stakeholders, these data are infrequently used for evaluating specialty pharmacy performance or clinical decision-making. Establishing standardized specialty pharmacy measures could enable benchmarking, performance-based contracting, and high-cost drug utilization management while improving patient care and specialty medication management.<h4>Objective</h4>To determine consensus among specialty pharmacy stakeholders on important and usable measures for specialty pharmacies managing patients with rheumatoid arthritis (RA).<h4>Methods</h4>A modified Delphi study was conducted with a multisite study group (n = 25 sites). Expert panelists from diverse RA-related backgrounds participa"],"journal":["Journal of managed care & specialty pharmacy"],"pagination":["360-373"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12948757"],"repository":["biostudies-literature"],"pubmed_title":["Finding consensus on meaningful reporting measures for rheumatoid arthritis: Results from a modified Delphi study."],"pmcid":["PMC12948757"],"pubmed_authors":["Plaia G","Stutsky M","Gazda NP","O'Reilly EA","Choi L","Dornbush NL","DeClercq J","Vest MH","Liang D","Lopez-Medina AI","Simonson D","Rector A","Brown M","St James G","Zuckerman AD","Thomas KC","Costigan B"],"additional_accession":[]},"is_claimable":false,"name":"Finding consensus on meaningful reporting measures for rheumatoid arthritis: Results from a modified Delphi study.","description":"<h4>Background</h4>Though specialty pharmacies collect and report a myriad of measures to internal and external stakeholders, these data are infrequently used for evaluating specialty pharmacy performance or clinical decision-making. Establishing standardized specialty pharmacy measures could enable benchmarking, performance-based contracting, and high-cost drug utilization management while improving patient care and specialty medication management.<h4>Objective</h4>To determine consensus among specialty pharmacy stakeholders on important and usable measures for specialty pharmacies managing patients with rheumatoid arthritis (RA).<h4>Methods</h4>A modified Delphi study was conducted with a multisite study group (n = 25 sites). Expert panelists from diverse RA-related backgrounds participa","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Mar","modification":"2026-07-16T23:24:42.898Z","creation":"2026-07-12T03:11:18.276Z"},"accession":"S-EPMC12948757","cross_references":{"pubmed":["41760564"],"doi":["10.18553/jmcp.2026.32.3.360"]}}